marketcaparena
Search

    STRO

    SUTRO BIOPHARMA, INC.

    Company overview

    Market capitalization
    $265.80M
    Employees
    133
    Latest publication
    2026-09-29
    About SUTRO BIOPHARMA, INC.

    Sutro Biopharma, Inc. operates as an oncology company. The company develops site-specific and novel-format antibody drug conjugates (ADCs) that enables its proprietary integrated cell-free protein synthesis platform, XpressCF; and site-specific conjugation platform, XpressCF+. Its lead product candidate includes STRO-004, a tissue factor (TF) targeting ADC for the treatment of TF-expressing solid tumors, including non-small cell lung cancer, head and neck squamous cell carcinoma, cervical cancer, colorectal cancer, pancreatic ductal adenocarcinoma, endometrial cancer, and bladder cancer. The company also develops VAX-24 and Vax-31 pneumococcal conjugate vaccine candidates that is in Phase II/III clinical trials for the treatment of invasive pneumococcal disease in adults and adults and infants; and STRO-003, an ADC directed against an anti-receptor tyrosine kinase-like orphan receptor 1 (ROR1) for the treatment of solid tumors, such as triple negative breast cancer, non-small cell lung cancer, and ovarian cancer, as well as hematological cancers. Sutro Biopharma, Inc. has collaboration and license agreements with Vaxcyte to discover and develop vaccine candidates for the treatment or prophylaxis of infectious diseases; Tasly Biopharmaceuticals Co., Ltd. to develop and commercialize STRO-002 in Greater China; Ipsen to develop and commercialize STRO-003, an ADC targeting ROR1; and Astellas Pharma Inc. to develop immunostimulatory ADC. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ4 20232023-12-31 · USD
    Total Revenue9,839,000USD11,647,000USD9,693,000USD63,745,000USD17,399,000USD14,809,000USD8,520,000USD113,721,000USD
    Research Development31,695,000USD36,642,000USD39,853,000USD38,325,000USD51,597,000USD71,037,000USD62,108,000USD53,765,000USD
    Selling General Administrative7,831,000USD8,662,000USD8,741,000USD10,343,000USD13,273,000USD9,030,000USD14,331,000USD16,804,000USD
    General And Administrative Expenses7,831,000USD———————
    Total Operating Expenses39,727,000USD45,304,000USD58,152,000USD67,090,000USD85,913,000USD80,067,000USD76,439,000USD70,569,000USD
    Operating Income-29,888,000USD-33,657,000USD-48,459,000USD-3,345,000USD-68,514,000USD-65,258,000USD-67,919,000USD43,152,000USD
    Total Other Income Expense Net-8,644,000USD-13,187,000USD-8,398,000USD-8,172,000USD-7,454,000USD-4,830,000USD19,132,000USD3,720,000USD
    Income Before Tax-38,532,000USD-46,844,000USD-56,857,000USD-11,517,000USD-75,968,000USD-70,088,000USD-48,787,000USD46,872,000USD
    Income Tax Expense1,000USD-82,000USD—-18,000USD—2,355,000USD—15,807,000USD
    Net Income-38,533,000USD-46,762,000USD-56,857,000USD-11,499,000USD-75,968,000USD-72,443,000USD-48,787,000USD31,065,000USD
    Cost Of Revenue—1,624,000USD1,900,000USD1,900,000USD—-1,738,000USD1,799,000USD1,731,000USD
    Gross Profit—11,647,000USD9,693,000USD63,745,000USD17,399,000USD14,809,000USD8,520,000USD113,721,000USD
    Interest Income—1,534,000USD2,009,000USD2,519,000USD3,189,000USD3,860,000USD27,042,000USD4,558,000USD
    Interest Expense—10,329,000USD10,407,000USD9,647,000USD10,643,000USD8,690,000USD7,910,000USD8,732,000USD
    Net Interest Income—-8,795,000USD-8,398,000USD-8,172,000USD-7,454,000USD-4,830,000USD19,132,000USD-4,174,000USD
    Tax Provision—-82,000USD0USD-18,000USD7,000USD2,355,000USD0USD15,807,000USD
    Net Income From Continuing Ops—-46,762,000USD-56,857,000USD-11,499,000USD-75,968,000USD-72,443,000USD-48,787,000USD31,065,000USD
    Ebit—-36,515,000USD-46,450,000USD-826,000USD-47,471,000USD-61,398,000USD-40,877,000USD55,604,000USD
    Ebitda—-34,891,000USD-44,550,000USD1,074,000USD-45,571,000USD-59,530,000USD-39,078,000USD57,335,000USD
    Depreciation And Amortization—1,624,000USD1,900,000USD1,900,000USD1,900,000USD1,868,000USD1,799,000USD1,731,000USD
    Reconciled Depreciation—1,624,000USD1,900,000USD1,900,000USD1,900,000USD1,868,000USD1,799,000USD1,731,000USD
    Unclassified Operating Expenses——9,558,000USD18,422,000USD21,043,000USD———
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20172017-12-31 · USDFY 20162016-12-31 · USD
    Total Revenue51,741,000USD59,731,000USD
    Cost Of Revenue51,897,000USD43,550,000USD
    Gross Profit-156,000USD16,181,000USD
    Research Development54,639,000USD43,550,000USD
    Selling General Administrative16,374,000USD14,817,000USD
    Total Operating Expenses71,013,000USD58,367,000USD
    Operating Income-19,272,000USD1,364,000USD
    Interest Income273,000USD251,000USD
    Interest Expense689,000USD0USD
    Net Interest Income-339,000USD251,000USD
    Income Before Tax-19,688,000USD1,702,000USD
    Income Tax Expense535,000USD87,000USD
    Net Income-19,688,000USD1,702,000USD
    Net Income From Continuing Ops-19,688,000USD1,702,000USD
    Ebit-19,076,000USD1,702,000USD
    Ebitda-14,086,000USD7,364,000USD
    Depreciation And Amortization4,990,000USD5,662,000USD
    Reconciled Depreciation4,990,000USD—
    Total Other Income Expense Net-416,000USD338,000USD
    Net Income Applicable To Common Shares-19,688,000USD-19,688,000USD
    SourceLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets194,462,000USD241,988,000USD173,830,000USD209,658,000USD262,355,000USD321,430,000USD387,207,000USD451,832,000USD
    Cash And Equivalents54,335,000USD———————
    Cash And Short Term Investments164,346,000USD202,558,000USD141,428,000USD167,594,000USD205,131,000USD248,972,000USD316,895,000USD388,254,000USD
    Short Term Investments110,011,000USD128,876,000USD83,298,000USD101,667,000USD141,106,000USD142,743,000USD126,591,000USD213,675,000USD
    Long Term Investments0USD———————
    Total Current Assets175,647,000USD220,972,000USD150,926,000USD182,113,000USD231,630,000USD287,409,000USD343,310,000USD405,779,000USD
    Other Current Assets5,504,000USD5,930,000USD5,521,000USD10,597,000USD18,500,000USD24,875,000USD17,799,000USD10,870,000USD
    Other Non Current Assets1,133,000USD———————
    Total Liabilities297,779,000USD———————
    Total Current Liabilities52,898,000USD70,811,000USD75,133,000USD71,895,000USD74,246,000USD133,046,000USD131,893,000USD131,291,000USD
    Other Current Liabilities2,728,000USD———————
    Other Non Current Liabilities1,694,000USD———————
    Total Stockholder Equity-103,317,000USD-66,887,000USD-132,452,000USD-87,268,000USD-32,111,000USD-25,811,000USD44,601,000USD111,220,000USD
    Total Equity Including Noncontrolling Interest-103,317,000USD———————
    Deferred Revenue6,456,000USD———————
    Deferred Revenue Non Current0USD———————
    Net Receivables5,797,000USD12,484,000USD3,977,000USD3,922,000USD7,999,000USD13,562,000USD8,616,000USD6,655,000USD
    Property Plant Equipment Net16,824,000USD19,070,000USD21,551,000USD26,687,000USD29,817,000USD33,078,000USD35,867,000USD38,024,000USD
    Accounts Payable3,356,000USD5,485,000USD7,565,000USD7,034,000USD4,308,000USD8,180,000USD10,475,000USD6,216,000USD
    Short Term Debt6,660,000USD7,600,000USD7,783,000USD7,960,000USD8,057,000USD7,765,000USD7,480,000USD7,203,000USD
    Common Stock17,000USD17,000USD9,000USD85,000USD85,000USD84,000USD83,000USD82,000USD
    Retained Earnings-1,054,972,000USD-1,016,439,000USD-977,955,000USD-931,193,000USD-874,336,000USD-862,837,000USD-786,869,000USD-714,426,000USD
    Accumulated Other Comprehensive Income-58,000USD-101,000USD19,000USD33,000USD-13,000USD-9,000USD39,000USD106,000USD
    Total Liab—308,875,000USD306,282,000USD296,926,000USD294,466,000USD347,241,000USD342,606,000USD340,612,000USD
    Other Current Liab—48,327,000USD49,223,000USD47,924,000USD49,917,000USD48,125,000USD44,137,000USD45,312,000USD
    Capital Stock—17,000USD9,000USD85,000USD85,000USD84,000USD83,000USD82,000USD
    Cash—73,682,000USD58,130,000USD65,927,000USD64,025,000USD106,229,000USD190,304,000USD174,579,000USD
    Current Deferred Revenue—9,399,000USD10,562,000USD8,977,000USD11,964,000USD68,976,000USD69,783,000USD72,560,000USD
    Net Debt—-60,050,000USD177,080,000USD-48,266,000USD155,652,000USD-84,832,000USD-167,150,000USD-149,715,000USD
    Short Long Term Debt Total—13,632,000USD235,210,000USD17,661,000USD219,677,000USD21,397,000USD23,154,000USD24,864,000USD
    Property Plant Equipment Gross—19,070,000USD48,903,000USD26,687,000USD29,817,000USD33,078,000USD84,497,000USD38,024,000USD
    Common Stock Shares Outstanding—130,823shares8,584,309shares8,486,986shares8,458,013shares8,310,601shares8,252,643shares8,204,367shares
    Non Current Assets Total—21,016,000USD22,904,000USD27,545,000USD30,725,000USD34,021,000USD43,897,000USD46,053,000USD
    Non Current Liabilities Total—238,064,000USD231,149,000USD225,031,000USD220,220,000USD214,195,000USD210,713,000USD209,321,000USD
    Non Current Liabilities Other—1,694,000USD1,694,000USD1,694,000USD1,694,000USD1,694,000USD1,694,000USD1,694,000USD
    Non Currrent Assets Other—1,946,000USD495,000USD858,000USD50,000USD943,000USD8,030,000USD8,029,000USD
    Net Working Capital—150,161,000USD75,793,000USD110,218,000USD157,384,000USD154,363,000USD211,417,000USD274,488,000USD
    Unclassified Non Current Liabilities—236,370,000USD229,455,000USD223,337,000USD218,526,000USD212,501,000USD209,019,000USD207,627,000USD
    Unclassified Equity—949,619,000USD845,466,000USD843,722,000USD842,068,000USD836,867,000USD831,265,000USD825,376,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets173,830,000USD387,207,000USD470,736,000USD406,944,000USD341,408,000USD394,111,000USD156,370,000USD223,139,000USD
    Other Current Assets5,521,000USD17,799,000USD9,846,000USD11,667,000USD8,123,000USD4,486,000USD4,406,000USD5,930,000USD
    Total Liab306,282,000USD342,606,000USD321,087,000USD189,896,000USD88,844,000USD62,063,000USD58,581,000USD91,600,000USD
    Total Stockholder Equity-132,452,000USD44,601,000USD149,649,000USD217,048,000USD252,564,000USD332,048,000USD97,789,000USD131,539,000USD
    Other Current Liab49,223,000USD44,137,000USD37,994,000USD23,321,000USD19,819,000USD627,000USD6,918,000USD7,064,000USD
    Common Stock9,000USD83,000USD61,000USD58,000USD46,000USD46,000USD23,000USD23,000USD
    Capital Stock9,000USD83,000USD61,000USD58,000USD46,000USD46,000USD23,000USD23,000USD
    Retained Earnings-977,955,000USD-786,869,000USD-559,408,000USD-452,615,000USD-333,411,000USD-227,873,000USD-195,745,000USD-150,328,000USD
    Cash58,130,000USD190,304,000USD69,268,000USD47,254,000USD30,414,000USD206,152,000USD4,960,000USD125,298,000USD
    Cash And Short Term Investments141,428,000USD316,895,000USD375,618,000USD334,364,000USD197,938,000USD368,137,000USD117,864,000USD204,492,000USD
    Total Current Assets150,926,000USD343,310,000USD421,542,000USD353,153,000USD218,515,000USD378,182,000USD128,568,000USD209,946,000USD
    Total Current Liabilities75,133,000USD131,893,000USD93,746,000USD66,547,000USD41,736,000USD29,597,000USD32,967,000USD36,423,000USD
    Current Deferred Revenue10,562,000USD69,783,000USD20,666,000USD16,759,000USD5,496,000USD14,603,000USD19,465,000USD21,574,000USD
    Net Debt-42,456,000USD-167,150,000USD-35,633,000USD7,761,000USD26,960,000USD-181,607,000USD4,916,000USD-110,574,000USD
    Short Term Debt7,783,000USD7,480,000USD10,481,000USD21,670,000USD10,412,000USD8,823,000USD1,000,000USD4,724,000USD
    Short Long Term Debt Total15,674,000USD23,154,000USD33,635,000USD55,015,000USD57,374,000USD33,368,000USD9,876,000USD14,724,000USD
    Short Term Investments83,298,000USD126,591,000USD306,350,000USD287,110,000USD167,524,000USD161,985,000USD112,904,000USD79,194,000USD
    Net Receivables3,977,000USD8,616,000USD36,078,000USD7,122,000USD12,454,000USD5,559,000USD6,298,000USD2,489,000USD
    Accounts Payable7,565,000USD10,475,000USD9,440,000USD4,797,000USD6,009,000USD5,544,000USD5,584,000USD3,061,000USD
    Property Plant Equipment Net21,551,000USD35,867,000USD44,755,000USD51,064,000USD51,591,000USD12,935,000USD9,633,000USD10,934,000USD
    Property Plant Equipment Gross48,903,000USD84,497,000USD86,918,000USD51,064,000USD85,017,000USD12,935,000USD9,633,000USD10,934,000USD
    Accumulated Other Comprehensive Income19,000USD39,000USD21,000USD-618,000USD-314,000USD129,000USD165,000USD-47,000USD
    Common Stock Shares Outstanding8,497,798shares7,682,920shares6,016,354shares5,073,919shares4,611,909shares32,573,469shares2,295,858shares2,286,508shares
    Non Current Assets Total22,904,000USD43,897,000USD49,194,000USD53,791,000USD122,893,000USD15,929,000USD27,801,999USD13,193,000USD
    Non Current Liabilities Total231,149,000USD210,713,000USD227,341,000USD123,349,000USD47,108,000USD32,466,000USD25,614,000USD55,177,000USD
    Non Current Liabilities Other1,694,000USD1,694,000USD1,694,000USD119,000USD146,000USD481,000USD134,000USD102,000USD
    Non Currrent Assets Other1,353,000USD8,030,000USD4,439,000USD34,747,000USD2,527,000USD2,122,000USD2,544,999USD2,244,000USD
    Net Working Capital75,793,000USD211,417,000USD327,796,000USD286,606,000USD176,779,000USD348,585,000USD95,601,000USD173,523,000USD
    Unclassified Non Current Liabilities229,455,000USD209,019,000USD225,647,000USD29,455,000USD31,078,000USD-1,821,000USD——
    Unclassified Equity845,466,000USD831,265,000USD708,914,000USD670,165,000USD586,197,000USD559,700,000USD293,323,000USD281,868,000USD
    Short Long Term Debt——4,061,000USD12,500,000USD9,375,000USD—1,000,000USD4,724,000USD
    Inventory——1USD-11,667,000USD1USD——1USD
    Unclassified Current Liabilities——11,104,000USD-12,500,000USD-9,375,000USD——-4,724,000USD
    Other Liab———90,004,000USD146,000USD7,921,000USD16,738,000USD45,177,000USD
    Other Assets———2,727,000USD122,893,000USD2,994,000USD2,560,000USD2,259,000USD
    Long Term Debt———3,771,000USD15,738,000USD24,545,000USD8,876,000USD10,000,000USD
    Long Term Investments———32,020,000USD68,775,000USD0USD15,609,000USD—
    Net Tangible Assets———217,048,000USD252,564,000USD332,048,000USD97,789,000USD131,539,000USD
    Unclassified Non Current Assets———-66,767,000USD-122,893,000USD-2,122,000USD-2,545,000USD-2,244,000USD
    Deferred Long Term Liab—————1,340,000USD409,000USD476,000USD
    Unclassified Current Assets———————-2,965,001USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation2,540,000USD
    Stock Based Compensation3,572,000USD
    Other Non Cash Items-206,000USD
    Change To Account Receivables-1,820,000USD
    Change To Liabilities-4,232,000USD
    Change In Working Capital-15,130,000USD
    Operating Cash Flow-80,549,000USD
    Net Investments-152,551,000USD
    Unclassified Investing Cash Flow126,648,000USD
    Investing Cash Flow-25,903,000USD
    Common Stock Issuance81,000USD
    Net Common Stock Issuance-160,000USD
    Unclassified Financing Cash Flow102,736,000USD
    Financing Cash Flow102,657,000USD
    Change In Cash-3,795,000USD
    End Cash Flow55,193,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-38,484,000USD-46,762,000USD-56,857,000USD-11,499,000USD-75,968,000USD-72,443,000USD-48,787,000USD-48,018,000USD
    Depreciation1,278,000USD1,624,000USD1,900,000USD1,900,000USD1,900,000USD1,868,000USD1,799,000USD1,790,000USD
    Stock Based Compensation1,562,000USD1,655,000USD1,552,000USD5,263,000USD5,538,000USD5,915,000USD6,545,000USD6,159,000USD
    Other Non Cash Items10,327,000USD12,369,000USD10,567,000USD10,193,000USD9,793,000USD8,657,000USD-16,953,000USD1,153,000USD
    Change To Account Receivables-8,507,000USD-55,000USD4,077,000USD5,563,000USD-4,946,000USD-1,961,000USD295,000USD24,350,000USD
    Change In Working Capital-16,942,000USD4,679,000USD4,649,000USD-50,581,000USD-9,146,000USD-15,735,000USD-7,120,000USD48,371,000USD
    Total Cash From Operating Activities-42,259,000USD-26,435,000USD-38,189,000USD-44,724,000USD-67,883,000USD-71,738,000USD-64,516,000USD9,455,000USD
    Capital Expenditures-11,000USD-184,000USD-251,000USD-86,000USD-1,174,000USD-1,068,000USD-828,000USD-756,000USD
    Free Cash Flow-42,270,000USD-26,619,000USD-38,440,000USD-44,810,000USD-69,057,000USD-72,806,000USD-65,344,000USD8,699,000USD
    Investments-45,253,000USD18,886,000USD39,989,000USD2,580,000USD-16,258,000USD87,488,000USD147,290,000USD-80,375,000USD
    Total Cashflows From Investing Activities-45,264,000USD18,702,000USD39,989,000USD2,580,000USD-16,258,000USD87,488,000USD147,290,000USD-80,375,000USD
    Total Cash From Financing Activities103,075,000USD-64,000USD102,000USD-60,000USD66,000USD-24,000USD1,017,000USD96,490,000USD
    Issuance Of Capital Stock103,126,000USD0USD0USD0USD0USD0USD0USD96,527,000USD
    Change In Cash15,552,000USD-7,797,000USD1,902,000USD-42,204,000USD-84,075,000USD15,726,000USD83,791,000USD25,570,000USD
    Begin Period Cash Flow58,130,000USD66,785,000USD64,025,000USD107,087,000USD191,162,000USD175,436,000USD91,645,000USD66,075,000USD
    End Period Cash Flow73,682,000USD58,988,000USD65,927,000USD64,883,000USD107,087,000USD191,162,000USD175,436,000USD91,645,000USD
    Other Cashflows From Financing Activities-160,000USD-67,000USD-25,000USD-60,000USD-180,000USD-24,000USD-74,000USD-37,000USD
    Net Borrowings—0USD0USD0USD0USD0USD0USD—
    Sale Purchase Of Stock———-60,000USD—-24,000USD374,000USD-37,000USD
    Unclassified Investing Cash Flow————1,174,000USD1,068,000USD-73,219,000USD—
    Other Cashflows From Investing Activities——————74,047,000USD—
    Unclassified Financing Cash Flow———————96,564,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-191,086,000USD-227,461,000USD-106,793,000USD-119,204,000USD-105,538,000USD-32,128,000USD-55,744,000USD-35,317,000USD
    Depreciation7,324,000USD7,218,000USD6,816,000USD5,690,000USD4,844,000USD4,297,000USD4,777,000USD4,539,000USD
    Stock Based Compensation14,008,000USD24,687,000USD24,908,000USD26,304,000USD23,241,000USD11,917,000USD10,312,000USD2,872,000USD
    Other Non Cash Items42,922,000USD-4,884,000USD-2,172,000USD-13,646,000USD6,159,000USD606,000USD193,000USD-517,000USD
    Change To Account Receivables4,639,000USD27,462,000USD-28,956,000USD5,341,000USD-6,895,000USD739,000USD-3,809,000USD-865,000USD
    Change In Working Capital-50,399,000USD8,900,000USD-34,375,000USD104,405,000USD-17,620,000USD-11,486,000USD-23,264,000USD42,606,000USD
    Total Cash From Operating Activities-177,231,000USD-191,540,000USD-111,616,000USD3,549,000USD-81,679,000USD-67,802,000USD-65,023,000USD12,683,000USD
    Capital Expenditures-1,695,000USD-3,098,000USD-4,315,000USD-7,858,000USD-15,323,000USD-7,129,000USD-3,481,000USD-1,557,000USD
    Free Cash Flow-178,926,000USD-194,638,000USD-115,931,000USD-4,309,000USD-97,002,000USD-74,931,000USD-68,504,000USD11,126,000USD
    Investments46,708,000USD218,508,000USD-18,293,000USD-35,022,000USD-82,001,000USD604,000USD-67,650,000USD-78,713,000USD
    Total Cashflows From Investing Activities45,013,000USD218,508,000USD-3,924,000USD-35,022,000USD-97,315,000USD604,000USD-51,131,000USD-80,190,000USD
    Net Borrowings0USD-4,083,000USD-12,500,000USD-9,375,000USD-9,375,000USD15,000,000USD-5,000,000USD-5,000,000USD
    Total Cash From Financing Activities44,000USD94,054,000USD137,554,000USD48,313,000USD3,256,000USD269,247,000USD-4,184,000USD170,785,000USD
    Issuance Of Capital Stock0USD96,527,000USD27,316,000USD56,270,000USD135,977,000USD251,415,000USD91,411,000USD169,175,000USD
    Change In Cash-132,174,000USD121,022,000USD22,014,000USD16,840,000USD-175,738,000USD202,049,000USD-120,338,000USD103,278,000USD
    Begin Period Cash Flow191,162,000USD70,140,000USD48,126,000USD31,286,000USD207,024,000USD4,975,000USD125,313,000USD22,035,000USD
    End Period Cash Flow58,988,000USD191,162,000USD70,140,000USD48,126,000USD31,286,000USD207,024,000USD4,975,000USD125,313,000USD
    Other Cashflows From Financing Activities-332,000USD1,610,000USD138,083,000USD1,418,000USD3,263,000USD2,832,000USD1,143,000USD86,349,000USD
    Unclassified Investing Cash Flow—3,098,000USD18,684,000USD36,588,000USD—7,040,000USD67,650,000USD—
    Sale Purchase Of Stock——-490,000USD-463,000USD-7,000USD-314,000USD-327,000USD84,436,000USD
    Unclassified Financing Cash Flow——12,461,000USD57,196,000USD9,375,000USD252,043,000USD—5,000,000USD
    Change To Liabilities———92,423,000USD-8,774,000USD-15,904,000USD2,239,000USD3,338,000USD
    Dividends Paid———-463,000USD—-314,000USD-297,000USD—
    Other Cashflows From Investing Activities———-28,730,000USD9,000USD89,000USD-47,650,000USD80,000USD
    Change To Inventory————-4,545,000USD-58,000USD-1,255,000USD-1,669,000USD
    Cash And Cash Equivalents Changes————-175,738,000USD202,049,000USD-120,338,000USD103,278,000USD
    Unclassified Operating Cash Flow————7,235,000USD-41,008,000USD-1,297,000USD-1,500,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31ProductFinancing Component On Unearned Revenue911,000USD0001193125-26-224170
    Q1 2026Quarterly · 2026-03-31ProductMaterials Supply1,083,000USD0001193125-26-224170
    Q1 2026Quarterly · 2026-03-31ProductOngoing Performance Related To Unsatisfied Performance Obligations11,958,000USD0001193125-26-224170
    Q1 2026Quarterly · 2026-03-31ProductResearch And Development Services571,000USD0001193125-26-224170
    FY 2025Yearly · 2025-12-31ProductContingent Payment0USD0001193125-26-119873
    FY 2025Yearly · 2025-12-31ProductFinancing Component On Unearned Revenue3,413,000USD0001193125-26-119873
    FY 2025Yearly · 2025-12-31ProductMaterials Supply13,641,000USD0001193125-26-119873
    FY 2025Yearly · 2025-12-31ProductOngoing Performance Related To Unsatisfied Performance Obligations82,319,000USD0001193125-26-119873
    FY 2025Yearly · 2025-12-31ProductResearch And Development Services3,111,000USD0001193125-26-119873
    Q3 2025Quarterly · 2025-09-30ProductFinancing Component On Unearned Revenue646,000USD0001193125-25-270036
    Q3 2025Quarterly · 2025-09-30ProductMaterials Supply2,439,000USD0001193125-25-270036
    Q3 2025Quarterly · 2025-09-30ProductOngoing Performance Related To Unsatisfied Performance Obligations5,955,000USD0001193125-25-270036
    Q3 2025Quarterly · 2025-09-30ProductResearch And Development Services653,000USD0001193125-25-270036
    Q2 2025Quarterly · 2025-06-30ProductFinancing Component On Unearned Revenue832,000USD0000950170-25-105219
    Q2 2025Quarterly · 2025-06-30ProductMaterials Supply6,205,000USD0000950170-25-105219
    Q2 2025Quarterly · 2025-06-30ProductOngoing Performance Related To Unsatisfied Performance Obligations55,839,000USD0000950170-25-105219
    Q2 2025Quarterly · 2025-06-30ProductOther96,000USD0000950170-25-105219
    Q2 2025Quarterly · 2025-06-30ProductResearch And Development Services773,000USD0000950170-25-105219
    Q1 2025Quarterly · 2025-03-31ProductFinancing Component On Unearned Revenue1,176,000USD0001193125-26-224170
    Q1 2025Quarterly · 2025-03-31ProductMaterials Supply1,848,000USD0001193125-26-224170
    Q1 2025Quarterly · 2025-03-31ProductOngoing Performance Related To Unsatisfied Performance Obligations12,958,000USD0001193125-26-224170
    Q1 2025Quarterly · 2025-03-31ProductOther297,000USD0001193125-26-224170
    Q1 2025Quarterly · 2025-03-31ProductResearch And Development Services1,120,000USD0001193125-26-224170
    FY 2024Yearly · 2024-12-31ProductContingent Payment5,000,000USD0001193125-26-119873
    FY 2024Yearly · 2024-12-31ProductFinancing Component On Unearned Revenue6,289,000USD0001193125-26-119873
    FY 2024Yearly · 2024-12-31ProductMaterials Supply3,104,000USD0001193125-26-119873
    FY 2024Yearly · 2024-12-31ProductOngoing Performance Related To Unsatisfied Performance Obligations39,900,000USD0001193125-26-119873
    FY 2024Yearly · 2024-12-31ProductResearch And Development Services7,731,000USD0001193125-26-119873
    Q3 2024Quarterly · 2024-09-30ProductFinancing Component On Unearned Revenue1,268,000USD0001193125-25-270036
    Q3 2024Quarterly · 2024-09-30ProductMaterials Supply190,000USD0001193125-25-270036
    Q3 2024Quarterly · 2024-09-30ProductOngoing Performance Related To Unsatisfied Performance Obligations5,095,000USD0001193125-25-270036
    Q3 2024Quarterly · 2024-09-30ProductOther37,000USD0001193125-25-270036
    Q3 2024Quarterly · 2024-09-30ProductResearch And Development Services1,930,000USD0001193125-25-270036
    Q2 2024Quarterly · 2024-06-30ProductFinancing Component On Unearned Revenue1,758,000USD0000950170-25-105219
    Q2 2024Quarterly · 2024-06-30ProductMaterials Supply296,000USD0000950170-25-105219
    Q2 2024Quarterly · 2024-06-30ProductOngoing Performance Related To Unsatisfied Performance Obligations21,590,000USD0000950170-25-105219
    Q2 2024Quarterly · 2024-06-30ProductResearch And Development Services2,049,000USD0000950170-25-105219
    Q1 2024Quarterly · 2024-03-31ProductFinancing Component On Unearned Revenue2,160,000USD0000950170-25-067072
    Q1 2024Quarterly · 2024-03-31ProductMaterials Supply372,000USD0000950170-25-067072
    Q1 2024Quarterly · 2024-03-31ProductOngoing Performance Related To Unsatisfied Performance Obligations7,230,000USD0000950170-25-067072
    Q1 2024Quarterly · 2024-03-31ProductOther976,000USD0000950170-25-067072
    Q1 2024Quarterly · 2024-03-31ProductResearch And Development Services2,270,000USD0000950170-25-067072
    FY 2023Yearly · 2023-12-31ProductContingent Payment5,000,000USD0000950170-25-038884
    FY 2023Yearly · 2023-12-31ProductFinancing Component On Unearned Revenue9,836,000USD0000950170-25-038884
    FY 2023Yearly · 2023-12-31ProductMaterials Supply3,802,000USD0000950170-25-038884
    FY 2023Yearly · 2023-12-31ProductOngoing Performance Related To Unsatisfied Performance Obligations17,015,000USD0000950170-25-038884
    FY 2023Yearly · 2023-12-31ProductOther11,467,000USD0000950170-25-038884
    FY 2023Yearly · 2023-12-31ProductResearch And Development Services9,111,000USD0000950170-25-038884
    FY 2023Yearly · 2023-12-31ProductUpfront Payment97,500,000USD0000950170-25-038884
    Q3 2023Quarterly · 2023-09-30ProductContingent Payment5,000,000USD0000950170-24-126407
    Q3 2023Quarterly · 2023-09-30ProductFinancing Component On Unearned Revenue2,456,000USD0000950170-24-126407
    Q3 2023Quarterly · 2023-09-30ProductMaterials Supply956,000USD0000950170-24-126407
    Q3 2023Quarterly · 2023-09-30ProductOngoing Performance Related To Unsatisfied Performance Obligations5,612,000USD0000950170-24-126407
    Q3 2023Quarterly · 2023-09-30ProductOther272,000USD0000950170-24-126407
    Q3 2023Quarterly · 2023-09-30ProductResearch And Development Services2,628,000USD0000950170-24-126407
    FY 2022Yearly · 2022-12-31ProductContingent Payment10,000,000USD0000950170-24-035949
    FY 2022Yearly · 2022-12-31ProductFinancing Component On Unearned Revenue5,079,000USD0000950170-24-035949
    FY 2022Yearly · 2022-12-31ProductMaterials Supply3,818,000USD0000950170-24-035949
    FY 2022Yearly · 2022-12-31ProductOngoing Performance Related To Unsatisfied Performance Obligations4,802,000USD0000950170-24-035949
    FY 2022Yearly · 2022-12-31ProductOther13,752,000USD0000950170-24-035949
    FY 2022Yearly · 2022-12-31ProductResearch And Development Services5,321,000USD0000950170-24-035949
    FY 2022Yearly · 2022-12-31ProductUpfront Payment25,000,000USD0000950170-24-035949
    FY 2021Yearly · 2021-12-31ProductContingent Payment2,000,000USD0000950170-24-035949
    FY 2021Yearly · 2021-12-31ProductFinancing Component On Unearned Revenue610,000USD0000950170-24-035949
    FY 2021Yearly · 2021-12-31ProductMaterials Supply8,041,000USD0000950170-24-035949
    FY 2021Yearly · 2021-12-31ProductOngoing Performance Related To Unsatisfied Performance Obligations35,098,000USD0000950170-24-035949
    FY 2021Yearly · 2021-12-31ProductOther11,483,000USD0000950170-24-035949
    FY 2021Yearly · 2021-12-31ProductResearch And Development Services4,648,000USD0000950170-24-035949
    FY 2020Yearly · 2020-12-31ProductMaterials Supply7,787,000USD0000950170-23-010976
    FY 2020Yearly · 2020-12-31ProductOngoing Performance Related To Unsatisfied Performance Obligations2,974,000USD0000950170-23-010976
    FY 2020Yearly · 2020-12-31ProductResearch And Development Services646,000USD0000950170-23-010976
    FY 2019Yearly · 2019-12-31ProductMaterials Supply6,814,000USD0000950170-22-002312
    FY 2019Yearly · 2019-12-31ProductOngoing Performance Related To Unsatisfied Performance Obligations3,936,000USD0000950170-22-002312
    FY 2019Yearly · 2019-12-31ProductResearch And Development Services571,000USD0000950170-22-002312
    FY 2017Yearly · 2017-12-31ProductCollaboration Revenue Milestones And Contingent Payments27,252,000USD0001564590-19-010253
    FY 2017Yearly · 2017-12-31ProductCollaboration Revenue Recognition Of Up Front Payment20,814,000USD0001564590-19-010253
    FY 2017Yearly · 2017-12-31ProductCollaboration Revenue Research And Development Services3,675,000USD0001564590-19-010253
    FY 2017Yearly · 2017-12-31ProductOther Revenue0USD0001564590-19-010253

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.